Clinical trial
An Open-label Extension Study of Ralinepag in Patients With Pulmonary Arterial Hypertension
NCT02279745 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Extension Study of Ralinepag in Patients With Pulmonary Arterial Hypertension
- Lead sponsor
- United Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 8, 2015
- Completion date
- March 29, 2021
- Enrollment
- 45 (actual)
- Sites
- 46
Conditions
As the registry lists them; a condition with its own page is linked.